mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib

Tim Meyer, Daniel H. Palmer, Ann Lii Cheng, Julia Hocke, Arsène Bienvenu Loembé, Chia Jui Yen

Research output: Contribution to journal › Article › peer-review

61 Citations (Scopus)

Fingerprint

Dive into the research topics of 'mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences